The effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graft

Introduction: Nowadays, cardiovascular diseases such as coronary heart disease are one of the most important causes of human mortality worldwide. Coronary artery bypass graft (CABG) surgery is a standard therapy approach for those suffering from coronary artery disease. Tranexamic acid (TXA), an ant...

Full description

Bibliographic Details
Main Authors: Alireza Rostami, Amin Haj Hoseini, Alireza Kamali
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Saudi Journal of Anaesthesia
Subjects:
Online Access:http://www.saudija.org/article.asp?issn=1658-354X;year=2020;volume=14;issue=4;spage=431;epage=435;aulast=Rostami
id doaj-7a063577f4e8478cab829d633cdb5a8d
record_format Article
spelling doaj-7a063577f4e8478cab829d633cdb5a8d2020-11-25T01:54:17ZengWolters Kluwer Medknow PublicationsSaudi Journal of Anaesthesia1658-354X2020-01-0114443143510.4103/sja.SJA_800_19The effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graftAlireza RostamiAmin Haj HoseiniAlireza KamaliIntroduction: Nowadays, cardiovascular diseases such as coronary heart disease are one of the most important causes of human mortality worldwide. Coronary artery bypass graft (CABG) surgery is a standard therapy approach for those suffering from coronary artery disease. Tranexamic acid (TXA), an antifibrinolytic drug, which, in turn, inhibits fibrinolysis, leading to the prevention of bleeding, thus, the present study aimed to evaluate the effect of topical TXA on bleeding reduction after coronary artery CABG. Materials and Methods: In this study 62 patients were randomly divided into two groups of TXA and control. After surgery and removal from the cardiopulmonary pump, TXA (2 g) was injected locally into the mediastinum by the surgeon. In the second group (control) the same amount of normal saline (100 cc) was given. Data were analyzed by SPSS 19 software via the t-test and Fisher's test. Results: A significant difference was found between the 2 groups in terms of postoperative hemorrhage, packed cell volume, platelet transfusion, duration of surgery, and received FFP (P = 0.0001; P = 0.01; P = 0.0001; P = 0.0001; P = 0.0001), where were found to be lower in the TXA group than in the placebo group. There was no significant difference in age, sex, return to the operating room, and discharge. Conclusion: The use of topical TXA in GABC significantly reduced postoperative hemorrhage, packed cell volume, platelet> transfusion, and FFP after surgery. Besides, it had no significant effect on the return to the operating room and mortality.http://www.saudija.org/article.asp?issn=1658-354X;year=2020;volume=14;issue=4;spage=431;epage=435;aulast=Rostamianti-fiberinolytic; local tranexamic acid; prophylaxis
collection DOAJ
language English
format Article
sources DOAJ
author Alireza Rostami
Amin Haj Hoseini
Alireza Kamali
spellingShingle Alireza Rostami
Amin Haj Hoseini
Alireza Kamali
The effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graft
Saudi Journal of Anaesthesia
anti-fiberinolytic; local tranexamic acid; prophylaxis
author_facet Alireza Rostami
Amin Haj Hoseini
Alireza Kamali
author_sort Alireza Rostami
title The effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graft
title_short The effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graft
title_full The effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graft
title_fullStr The effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graft
title_full_unstemmed The effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graft
title_sort effect of tranexamic acid in reducing postoperative hemorrhage in patients undergoing coronary artery bypass graft
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Anaesthesia
issn 1658-354X
publishDate 2020-01-01
description Introduction: Nowadays, cardiovascular diseases such as coronary heart disease are one of the most important causes of human mortality worldwide. Coronary artery bypass graft (CABG) surgery is a standard therapy approach for those suffering from coronary artery disease. Tranexamic acid (TXA), an antifibrinolytic drug, which, in turn, inhibits fibrinolysis, leading to the prevention of bleeding, thus, the present study aimed to evaluate the effect of topical TXA on bleeding reduction after coronary artery CABG. Materials and Methods: In this study 62 patients were randomly divided into two groups of TXA and control. After surgery and removal from the cardiopulmonary pump, TXA (2 g) was injected locally into the mediastinum by the surgeon. In the second group (control) the same amount of normal saline (100 cc) was given. Data were analyzed by SPSS 19 software via the t-test and Fisher's test. Results: A significant difference was found between the 2 groups in terms of postoperative hemorrhage, packed cell volume, platelet transfusion, duration of surgery, and received FFP (P = 0.0001; P = 0.01; P = 0.0001; P = 0.0001; P = 0.0001), where were found to be lower in the TXA group than in the placebo group. There was no significant difference in age, sex, return to the operating room, and discharge. Conclusion: The use of topical TXA in GABC significantly reduced postoperative hemorrhage, packed cell volume, platelet> transfusion, and FFP after surgery. Besides, it had no significant effect on the return to the operating room and mortality.
topic anti-fiberinolytic; local tranexamic acid; prophylaxis
url http://www.saudija.org/article.asp?issn=1658-354X;year=2020;volume=14;issue=4;spage=431;epage=435;aulast=Rostami
work_keys_str_mv AT alirezarostami theeffectoftranexamicacidinreducingpostoperativehemorrhageinpatientsundergoingcoronaryarterybypassgraft
AT aminhajhoseini theeffectoftranexamicacidinreducingpostoperativehemorrhageinpatientsundergoingcoronaryarterybypassgraft
AT alirezakamali theeffectoftranexamicacidinreducingpostoperativehemorrhageinpatientsundergoingcoronaryarterybypassgraft
AT alirezarostami effectoftranexamicacidinreducingpostoperativehemorrhageinpatientsundergoingcoronaryarterybypassgraft
AT aminhajhoseini effectoftranexamicacidinreducingpostoperativehemorrhageinpatientsundergoingcoronaryarterybypassgraft
AT alirezakamali effectoftranexamicacidinreducingpostoperativehemorrhageinpatientsundergoingcoronaryarterybypassgraft
_version_ 1724988080956375040